NEXT Biometrics Group ASA — AGM Information 2021

May 12, 2021

OFFICE TRANSLATION

PROTOKOLL FRA

ORDINÆR GENERALFORSAMLING

$\mathbf{r}$

NEXT BIOMETRICS GROUP ASA ORG. NR. 982 904 420

Det ble avholdt ordinær generalforsamling i NEXT Biometrics Group ASA ("Selskapet") 12. mai 2021 kl. 10:00 i Selskapets lokale i Apotekergata 10B i Oslo.

Generalforsamlingen ble åpnet av styrets leder, Petter Fjellstad.

Det ble opptatt en fortegnelse over aksjeeiere som var рå generalforsamlingen, representert enten ved forhåndsstemme, personlig oppmøte eller fullmektig. Fortegnelsen, inkludert antall aksjer og stemmer representert, er inntatt som Vedlegg 1 til protokollen.

23 232 969 av totalt 90 764 386 aksjer og stemmer i Selskapet, tilsvarende 25,60 % av aksjekapitalen, var representert på generalforsamlingen. Fortegnelsen ble enstemmig godkjent av generalforsamlingen.

Til behandling forelå følgende saker:

$\blacksquare$ VALG AV MØTELEDER

I samsvar med styrets forslag ble Petter Fjellstad valgt til møteleder.

Beslutningen ble truffet med nødvendig flertall, jf. avstemningsresultatet inntatt som Vedlegg 2 til protokollen.

$\overline{\mathbf{2}}$ GODKJENNELSE AV INNKALLING OG DAGSORDEN

Det ble opplyst om at innkallingen var blitt tilsendt samtlige aksjeeiere med kjent adresse den 21. april 2021.

Møtelederen reiste spørsmål om det var bemerkninger til innkallingen eller dagsordenen. Da det ikke var noen innvendinger, ble innkalling og dagsorden ansett som godkjent. Møtelederen erklærte generalforsamlingen som lovlig satt.

Beslutningen ble truffet med nødvendig flertall, jf. avstemningsresultatet inntatt som Vedlegg 2 til protokollen.

MINUTES OF

ANNUAL GENERAL MEETING

ΩF

NEXT BIOMETRICS GROUP ASA REG. NO. 982 904 420

The annual general meeting of NEXT Biometrics Group ASA (the "Company") was held on 12 May 2020 at 10:00 hours (CEST) at the premises of the Company in Apotekergata 10B in Oslo.

The meeting was opened by the chairman of the board of directors, Petter Fiellstad.

A register of shareholders present at the annual general meeting, either by advance vote, in person or by proxy, was completed. The register of attending shareholders, including the number of shares and votes represented, is enclosed to the minutes as Appendix 1.

23,232,969 of a total of 90,764,386 shares and votes in the Company, representing 25.60 % of the share capital, were represented at the general meeting. The list was unanimously approved by the general meeting.

The following matters were resolved:

$\mathbf{1}$ ELECTION OF A PERSON TO CHAIR THE MEETING

In accordance with board of directors' proposal, Petter Fjellstad was elected to chair the meeting.

The resolution was passed with the required majority, cf. the result of the voting set out in Appendix 2 to the minutes.

$\overline{\mathbf{z}}$ APPROVAL OF THE NOTICE AND THE AGENDA

The general meeting was informed that the notice of the general meeting had been sent to all shareholders with a known address on 21 April 2021.

The chairman of the meeting raised the question of whether there were any objections to the notice or the agenda of the general meeting. The notice and the agenda were approved without objections, and it was noted by the chairman of the meeting that the general meeting was lawfully convened.

The resolution was passed with the required majority, cf. the result of the voting set out in Appendix 2 to the minutes.

VALG AV EN PERSON TIL Å $\overline{\mathbf{3}}$ MEDUNDERTEGNE PROTOKOLLEN

Odd-Harald Hauge ble valgt til å undertegne protokollen sammen med møtelederen.

Beslutningen ble truffet med nødvendig flertall, jf. avstemningsresultatet inntatt som Vedlegg 2 til protokollen.

GODKJENNELSE AV ÅRSREGNSKAP OG $\overline{\mathbf{4}}$ ÅRSBERETNING FOR REGNSKAPSÅRET 2020

Selskapets årsregnskap og Selskapets årsrapport, herunder konsernregnskapet og årsberetningen, for regnskapsåret 2020, samt revisors beretning, er gjort tilgjengelig på Selskapets hjemmeside www.nextbiometrics.com i henhold til vedtektenes § 8.

Årsregnskapet og årsberetningen for regnskapsåret 2020, samt revisors beretning, ble presentert og gjennomgått.

I tråd med styrets forslag traff generalforsamlingen følgende vedtak:

Selskapets regnskap og Selskapets årsrapport, herunder konsernregnskap og årsberetning, for regnskapsåret 2020 godkjennes.

Beslutningen ble truffet med nødvendig flertall, jf. avstemningsresultatet inntatt som Vedlegg 2 til protokollen.

5 GODKJENNELSE AV GODTGJØRELSE TIL SELSKAPETS REVISOR FOR 2020

I samsvar med styrets forslag traff generalforsamlingen følgende vedtak:

Godtgjørelse etter regning til Selskapets revisor for revisjon og revisjonsrelaterte tjenester i regnskapsåret 2020 godkjennes.

Beslutningen ble truffet med nødvendig flertall, jf. avstemningsresultatet inntatt som Vedlegg 2 til protokollen.

6 VALG AV STYREMEDLEMMER

I samsvar med valgkomiteens innstilling ble følgende personer valgt til medlemmer av Selskapets styre for perioden frem til ordinær generalforsamling i 2022:

$\mathbf{3}$ ELECTION OF A PERSON TO CO-SIGN THE MINUTES

Odd-Harald Hauge was elected to sign the minutes together with the chairman of the meeting.

The resolution was passed with the required majority, cf. the result of the voting set out in Appendix 2 to the minutes.

4 APPROVAL OF THE ANNUAL ACCOUNTS AND THE ANNUAL REPORT FOR THE FINANCIAL YEAR 2020

The Company's annual accounts and the Company's annual report, including the group's annual accounts and the board of directors' report, for the financial year 2020, are, together with the auditor's report, available at the Company's website www.nextbiometrics.com in accordance with section 8 of the articles of association.

The annual accounts and the annual report for the financial year 2020, including the auditor's report, were presented and reviewed.

In accordance with the board of directors' proposal, the general meeting adopted the following resolution:

The Company's annual accounts and the Company's annual report, including the group's annual accounts and the board of directors' report, for the financial year 2020 are approved.

The resolution was passed with the required majority, cf. the result of the voting set out in Appendix 2 to the minutes.

5 APPROVAL OF REMUNERATION TO THE COMPANY'S AUDITOR FOR 2020

In accordance with the board of directors' proposal, the general meeting adopted the following resolution:

Remuneration based on invoices to the Company's auditor for audit and audit related services during the financial year 2020 is approved.

The resolution was passed with the required majority, cf. the result of the voting set out in Appendix 2 to the minutes.

6 ELECTION OF BOARD MEMBERS

In accordance with the Nomination Committee's proposal, the following persons were elected as members of the Company's board of directors for the period until the annual general meeting in 2022:

			BIOMETRICS
	Petter Fjellstad (styreleder)		Petter Fjellstad (chairman)
	Emine Lundkvist (styremedlem)	$\bullet$	Emine Lundkvist (board member)
	Odd Harald Hauge (styremedlem)		Odd Harald Hauge (board member)
	Live Haukvik (styremedlem)		Live Haukvik (board member)
	Beslutningen ble truffet med nødvendig flertall, jf. avstemningsresultatet inntatt som Vedlegg 2 til protokollen.		The resolution was passed with the required majority, cf. the result of the voting set out in Appendix 2 to the minutes.
7	GODTGJØRELSE TIL STYRETS MEDLEMMER	$\overline{ }$	REMUNERATION TO THE MEMBERS OF THE BOARD OF DIRECTORS
7.1	Godtgjørelse til styrets medlemmer for perioden fra den ordinære generalforsamlingen i 2021 til den ordinære generalforsamlingen i 2022	7.1	Remuneration to the members of the board of directors for the period from the annual general meeting in 2021 to the annual general meeting in 2022
I samsvar generalforsamling	valgkomiteens innstilling med traff generalforsamlingen følgende vedtak om godtgjørelse til styrets medlemmer for perioden fra Selskapets ordinære 2021 til i i Selskapets ordinære generalforsamling i 2022:	in 2022:	In accordance with the Nomination Committee's proposal, the general meeting adopted the following resolution regarding remuneration to the members of the board of directors for the period from the Company's annual general meeting in 2021 to the Company's annual general meeting
$\bullet$	Styrets leder: NOK 500 000	٠	Chair of the board: NOK 500,000
$\bullet$	Styremedlemmer: NOK 200 000 hver	$\bullet$	Board members: NOK 200,000 each
Beslutningen	ble truffet med nødvendig flertall, jf… avstemningsresultatet inntatt som Vedlegg 2 til protokollen.		The resolution was passed with the required majority, cf. the result of the voting set out in Appendix 2 to the minutes.
7.2	Tildeling av opsjoner til styrets medlemmer	7.2	Options to the members of the board of directors
	Valgkomiteen har innstilt på tildeling av opsjoner til styrets The Nomination Committee has proposed that options shall be

medlemmer, og det var i samsvar med dette i innkallingen til granted to the members of the board of directors, and in the generalforsamlingen foreslått at generalforsamlingen skulle notice of the general meeting it was in line with this proposed vedta tildeling av opsjoner til styremedlemmene. Basert på tilbakemeldinger fra aksjonærer i Selskapet hadde imidlertid styret forut for generalforsamlingen besluttet å trekke forslaget. Generalforsamlingen stemte dermed ikke over denne saken.

$7.3$ Godtgjørelse til medlemmer av underkomiteer til styret

Valgkomiteen har i sin innstilling til generalforsamlingen foreslått at det ikke skal utbetales godtgjørelse til medlemmer av underkomiteer til styret, herunder revisjonsutvalget og kompensasjonskomiteen. Det ble ikke fremsatt bemerkninger til dette.

that the general should resolve to grant options to the board members. However, the board of directors had prior to the general meeting resolved to withdraw the proposal based on responses received from shareholders. The general meeting did accordingly not vote on this agenda item.

$7.3$ Remuneration to the members of board committees

The Nomination Committee has in its recommendation to the general meeting proposed that no remuneration shall be paid to the members of board committees, including the audit committee and the remuneration committee. No remarks were made by the general meeting.

$\mathbf{a}$ VALG AV MEDLEMMER TIL VALGKOMITEEN

I samsvar med valgkomiteens innstilling ble følgende personer valgt som medlemmer av valgkomiteen:

• Jon Frode Vaksvik (leder)
• Haakon Sæter (medlem)

I tillegg ble Hans Herman Horn etter forslag fra aksjonærer valgt som medlem av valgkomiteen.

Beslutningen ble truffet med nødvendig flertall, jf. avstemningsresultatet inntatt som Vedlegg 2 til protokollen.

$\mathbf{Q}$ GODTGJØRELSE TIL VALGKOMITEENS MEDLEMMER

$\mathbf{I}$ samsvar med valgkomiteens innstilling, traff generalforsamlingen følgende vedtak om godtgjørelse til valgkomiteens medlemmer for perioden fra Selskapets ordinære generalforsamling i 2021 og frem til Selskapets ordinære generalforsamling i 2022:

• Leder: NOK 30 000
• Medlemmer: NOK 20 000 hver

Beslutningen ble truffet med nødvendig flertall, jf. avstemningsresultatet inntatt som Vedlegg 2 til protokollen.

10 STYRETS RETNINGSLINJER FOR FASTSETTELSE AV LØNN OG ANNEN GODTGJØRELSE TIL LEDENDE PERSONER

Styrets forslag til retningslinjer for fastsettelse av lønn og annen godtgjørelse til ledende personer i Selskapet er gjort tilgjengelig рă Selskapets hjemmeside www.nextbiometrics.com i henhold til vedtektenes § 8.

Styrets retningslinjer ble presentert og gjennomgått.

I samsvar med styrets forslag traff generalforsamlingen følgende vedtak:

Styrets forslag til retningslinjer for fastsettelse av lønn og annen godtgjørelse til ledende personer godkjennes.

$\overline{\mathbf{a}}$ ELECTION OF MEMBERS OF THE NOMINATION COMMITTEE

In accordance with the Nomination Committee's proposal, the following persons were elected as members of the Nomination Committee:

• Jon Frode Vaksvik (chair)
• Haakon Sæter (member)

In addition, Hans Herman Horn was elected as member of the Nomination Committee based on a proposal from shareholders.

The resolution was passed with the required majority, cf. the result of the voting set out in Appendix 2 to the minutes.

$\mathbf{Q}$ REMUNERATION TO THE MEMBERS OF THE NOMINATION COMMITTEE

In accordance with the Nomination Committee's proposal, the general meeting adopted the following resolution regarding remuneration to the members of the Nomination Committee for the period from the Company's annual general meeting in 2021 to the Company's annual general meeting in 2022:

• Chairperson: NOK 30,000
• Member: NOK 20,000 each

The resolution was passed with the required majority, cf. the result of the voting set out in Appendix 2 to the minutes.

10 THE BOARD OF DIRECTORS' GUIDELINES ON DETERMINATION OF SALARY AND OTHER REMUNERATION TO LEADING PERSONNEL

The board of directors' guidelines on determination of salary and other remuneration to leading personnel in the Company is available at the Company's website www.nextbiometrics.com in accordance with section 8 of the articles of association.

The board of directors' guidelines were presented and reviewed.

In accordance with the board of directors' proposal, the general meeting adopted the following resolution:

The board of directors' proposed guidelines on determination of salary and other remuneration to leading personnel are approved.

Beslutningen ble truffet med nødvendig flertall, if. avstemningsresultatet inntatt som Vedlegg 2 til protokollen.

$11$ REDEGJØRELSE FOR FORETAKSSTYRING

Det ble åpnet for spørsmål til redegiørelsen for foretaksstyring som er utarbeidet i samsvar med regnskapsloven § 3-3b. Det ble ikke fremsatt bemerkninger til redegjørelsen.

$12$ FULLMAKTER TIL STYRET

$12.1$ Fullmakt til å forhøye aksjekapitalen i forbindelse med Selskapets opsjonsprogram for ansatte og styret

Møteleder informerte generalforsamlingen om at styret i forkant av generalforsamlingen hadde besluttet å redusere den foreslåtte fullmaktens størrelse som følge av at det ikke skal tildeles nye opsjoner til styrets medlemmer (jf. sak 7.2). Opsjoner allerede tildelt styremedlemmene skal imidlertid kunne honoreres.

samsvar stvrets $\mathbf{I}$ med reviderte forslag traff generalforsamlingen følgende vedtak:

• $(i)$ I henhold til allmennaksjeloven § 10-14 gis styret fullmakt til å forhøye Selskapets aksjekapital med inntil NOK 7 930 000, hvorav inntil NOK 1,660,000 kan benyttes til å utstede aksjer til styrets medlemmer i henhold til opsjoner tildelt styrets medlemmer i 2019 og 2020.
• $(ii)$ Aksjeeiernes fortrinnsrett til de nye aksjene etter allmennaksjeloven § 10-4 kan fravikes.
• $(iii)$ Fullmakten omfatter kapitalforhøyelse mot innskudd i andre eiendeler enn penger mv., jf. allmennaksjeloven § 10-2.
• $(iv)$ Fullmakten omfatter ikke kapitalforhøyelse ved fusjon etter allmennaksjeloven § 13-5.
• $(v)$ Fullmakten gjelder frem til Selskapets ordinære generalforsamling i 2022, likevel ikke lenger enn til og med 30. juni 2022.
• $(vi)$ Fra tidspunktet for registrering i Foretaksregisteret erstatter denne fullmakten den tidligere fullmakten til å forhøye aksjekapitalen med inntil NOK 6 113 751,

The resolution was passed with the required majority, cf. the result of the voting set out in Appendix 2 to the minutes.

$11$ STATEMENT ON CORPORATE GOVERNANCE

It was opened up for questions relating to the statement on corporate governance prepared in accordance with section 3-3b of the Norwegian Accounting Act. No remarks to the statement were made by the general meeting.

AUTHORISATIONS TO THE BOARD OF $12$ DIRECTORS

$12.1$ Authorisation to increase the share capital in connection with the Company's share option program for employees and board members

The chairman informed the general meeting that the board of directors prior to the general meeting had resolved to reduce the size of the proposed authorisation as new options will not be granted to the members of the board (cf item 7.2). Options already granted to the members of the board shall however be honoured.

In accordance with the board of directors' revised proposal. the general meeting adopted the following resolution:

• $(i)$ Pursuant to section 10-14 of the Norwegian Public Limited Companies Act, the board of directors is granted an authorisation to increase the Company's share capital by up to NOK 7,930,000., out of which up to NOK 1,660,000 may be used to issue shares to board members under options granted to board members in 2019 and 2020.
• $(ii)$ The shareholders preferential right to the new shares pursuant to section 10-4 of the Norwegian Public Limited Companies Act may be deviated from.
• $(iii)$ The authorisation comprises share capital increase against contribution in kind, cf. section 10-2 of the Norwegian Public Limited Companies Act.
• The authorisation does not comprise share capital $(iv)$ increase in connection with mergers pursuant to section 13-5 of the Norwegian Public Limited Companies Act.
• $(v)$ The authorisation is valid until the Company's annual general meeting in 2022, but no longer than to and including 30 June 2022.
• From the time of registration in the Norwegian $(vi)$ Register of Business Enterprises, this authorization replaces the previous authorization to increase the share capital with up to NOK 6,113,751, given to the

som ble qitt i ekstraordinær generalforsamling 19. juni 2020.

Beslutningen ble truffet med nødvendig flertall, jf. avstemningsresultatet inntatt som Vedlegg 2 til protokollen.

$12.2$ Fullmakt til kapitalforhøyelse

I samsvar med styrets forslag traff generalforsamlingen følgende vedtak:

• I henhold til allmennaksjeloven § 10-14 gis styret $(i)$ fullmakt til å forhøye Selskapets aksjekapital med inntil NOK 18 150 000.
• $(ii)$ Aksjeeiernes fortrinnsrett til de nye aksjer etter allmennaksjeloven § 10-4 kan fravikes.
• $(iii)$ Fullmakten omfatter kapitalforhøyelse mot innskudd i andre eiendeler enn penger mv. etter allmennaksjeloven § 10-2.
• Fullmakten omfatter ikke kapitalforhøyelse ved fusjon $(iv)$ etter allmennaksieloven § 13-5.
• Fullmakten gjelder frem til Selskapets ordinære $(v)$ generalforsamling i 2022, likevel ikke lenger enn til og med 30. juni 2022.

Beslutningen ble truffet med nødvendig flertall, jf. avstemningsresultatet inntatt som Vedlegg 2 til protokollen.

board of directors in the extraordinary general meeting held on 19 June 2020.

The resolution was passed with the required majority, cf. the result of the voting set out in Appendix 2 to the minutes.

Authorisation to increase the share capital $12.2$

In accordance with the board of directors' proposal, the general meeting adopted the following resolution:

• Pursuant to section 10-14 of the Norwegian Public $(i)$ Limited Companies Act, the board of directors is granted an authorisation to increase the Company's share capital by up to NOK 18,150,000.
• The shareholders' preferential right to the new $(i)$ shares pursuant to Section 10-4 of the Norwegian Public Limited Companies Act may be deviated from.
• $(iii)$ The authorisation comprises share capital increase against contribution in kind, cf. section 10-2 of the Norwegian Public Limited Companies Act.
• $(iv)$ The authorisation does not comprise share capital increase in connection with mergers pursuant to section 13-5 of the Norwegian Public Limited Companies Act.
• The authorisation is valid until the Company's annual $(v)$ general meeting in 2022, but no longer than to and including 30 June 2022.

The resolution was passed with the required majority, cf. the result of the voting set out in Appendix 2 to the minutes.

$ * $

Mer forelå ikke til behandling.

Generalforsamlingen ble hevet.

There were no further matters to be discussed.

The general meeting was adjourned.

Oslo, 12. mai 2021 / 12 May 2021 Odd-Marald Hauge

APPENDICES:

$\mathbf{1}$

$\mathbf 2$

VEDLEGG:

• $\mathbf{1}$ Fortegnelse over de møtende aksjeeiere, samt angivelse av antall aksjer og stemmer

• $\overline{z}$ Stemmeresultater

• List of the present shareholders, with specification of the number of shares and votes

• Voting results

Total Represented

'ISIN:	NO0010629108 NEXT BIOMETRICS GROUP ASA
General meeting date: 12/05/2021 10.00
$ $ Today:	12.05.2021

Number of persons with voting rights represented/attended: 2

	Number of shares % sc
Total shares	90,764,386
- own shares of the company	0
Total shares with voting rights	90,764,386
Represented by own shares	832,779	0.92%
Represented by advance vote	2,494,427	2.75%
Sum own shares	3,327,206	3.67%
Represented by proxy	15,755,763	17.36 %
Represented by voting instruction	4,150,000	4.57 %
Sum proxy shares	19,905,763	21.93 %
Total represented with voting rights	23,232,969	25.60%
Total represented by share capital	23,232,969	25.60 %

Registrar for the company:

DNB Bank ASA

$\bar{\mathcal{A}}$

Fasci JΕ M

Signature company:

NEXT BIOMETRICS GROUP ASA

Poll not registered Represented shares

Protocol for general meeting NEXT BIOMETRICS GROUP ASA

Shares class	FOR	Against	Poll in	Abstain
Today:	12.05.2021
General meeting date: 12/05/2021 10.00
ISIN:	NO0010629108 NEXT BIOMETRICS GROUP ASA

						with voting rights
Agenda item 1 Election of Petter Fjellstad to chair the meeting
Ordinær	23,182,969	0	23,182,969	50,000	0	23,232,969
votes cast in %	100.00 %	0.00%		$0.00 \%$
representation of sc in %	99.79%	0.00 %	99.79%	0.22%	0.00%
total sc in %	25.54 %	0.00%	25.54 %	0.06%	0.00%
Total	23,182,969	0	23,182,969	50,000	0	23,232,969
Agenda item 2 Approval of the notice and the agenda
Ordinær	23,182,969	0	23,182,969	50,000	0	23,232,969
votes cast in %	100.00 %	0.00%		0.00%
representation of sc in %	99.79 %	0.00%	99.79%	0.22%	0.00%
total sc in %	25.54 %	0.00%	25,54 %	0.06%	0.00%
Total	23,182,969		0 23,182,969	50,000	$\bf o$	23,232,969
Agenda item 3 Election of Odd-Harald Hauge to co-sign the minutes
Ordinær	22,634,062	0	22,634,062	598,907	0	23,232,969
votes cast In %	100.00 %	0.00%		0.00%
representation of sc in %	97.42 %	0.00%	97.42 %	2.58 %	0.00%
total sc in %	24.94 %	0.00%	24.94 %	0.66%	0.00%
Total	22,634,062		0 22,634,062 598,907		o	23,232,969
Agenda item 4 Approval of the annual accounts and the annual report for the financial year 2020
Ordinær	23,182,969	0	23,182,969	50,000	$\Omega$	23,232,969
	100.00 %
votes cast in %		0.00%		0.00%
representation of sc in %	99.79%	0.00%	99.79 %	0.22%	$0.00 \%$
total sc in %	25.54 %	0.00%	25.54 %	0.06%	0.00%
Total	23,182,969	0	23,182,969	50,000	0	23,232,969
Agenda item 5 Approval of remuneration to the Company's auditor for 2020
Ordinær	23,182,969	0	23,182,969	50,000	0	23,232,969
votes cast in %	100.00 %	0.00%		0.00 %
representation of sc in %	99.79 %	0.00%	99.79 %	0.22%	0.00%
total sc in %	25.54 %	0.00%	25.54 %	0.06 %	0.00%
Total	23,182,969	0	23,182,969	50,000	0	23,232,969
Agenda item 6.1 Election of board members - Petter Fjellstad (chair)
Ordinær	23,182,969	0	23,182,969	50,000	0	23,232,969
votes cast in %	100,00 %	0.00%		0.00%
representation of sc in %	99.79 %	0.00%	99.79 %	0.22%	0.00%
total sc in %	25,54 %	0.00%	25.54 %	0.06%	0.00%
Total	23,182,969		0 23,182,969	50,000	0	23,232,969
Agenda item 6.2 Election of board members - Emine Lundkvist (board member)
Ordinær	23,182,969	0	23,182,969	50,000	0	23,232,969
votes cast in %	100.00 %	0.00 %		$0.00 \%$
representation of sc in %	99.79 %	0.00 %	99.79%	0.22%	$0.00 \%$
total sc in %	25.54 %	0.00%	25.54 %	0.06%	0.00%
Total	23,182,969	$\mathbf{o}$	23,182,969	50,000	0	23,232,969
Agenda item 6.3 Election of board members - Odd Harald Hauge (board member)
Ordinær	23,182,969	0	23,182,969	50,000	0	23,232,969
votes cast in %	100.00 %	$0.00 \%$		$0.00 \%$
representation of sc in %	99.79 %	0.00%	99.79%	0.22%	0.00%
total sc in %	25.54 %	0.00%	25.54 %	0.06%	0.00 %
Total	23,182,969		0 23,182,969	50,000	0	23,232,969
Agenda item 6.4 Election of board members - Live Haukvik (board member)
Ordinær	23,182,969	0	23,182,969	50,000	0	23,232,969
votes cast in %	100.00 %	0.00 %		0.00 %
representation of sc in %	99.79%	$0.00 \%$	99.79 %	0.22%	0.00 %
total sc in %	25.54 %	0.00 %	25.54%	0.06 %	0.00 %
Total	23,182,969		0 23,182,969	50,000	0	23,232,969

Agenda item 7.1 Remuneration to the members of the board of directors for the period from the annual general meeting in 2021 to the annual general meeting i

VPS GeneralMeeting

Shares class	FOR	Against	Poll in	Abstain		Poll not registered Represented shares with voting rights
Ordinær	22,673,262	504,702	23,177,964	55,005	0	23,232,969
votes cast in %	97.82 %	2.18%		0.00%
representation of sc in %	97.59 %	2,17 %	99.76 %	0.24%	0.00%
total sc in %	24.98%	0.56%	25.54 %	0.06%	0.00%
Total			22,673,262 504,702 23,177,964	55,005	0	23,232,969
Agenda item 8.1 Election of members of the Nomination Committee - Jon Frode Vaksvik (chair)
Ordinær	23,182,969	0	23,182,969	50,000	0	23,232,969
votes cast in %	100.00 %	0.00%		0,00%
representation of sc in %	99.79%	0,00%	99.79%	0.22%	0.00%
total sc in %	25.54 %	0.00%	25,54 %	0.06%	0.00%
Total	23,182,969		023,182,969	50,000	0	23,232,969
Agenda item 8.2 Election of members of the Nomination Committee - Haakon Sæter (member)
Ordinær	23,182,969	0	23,182,969	50,000	0	23,232,969
votes cast In %	100.00 %	0.00%		0.00 %
representation of sc in %	99.79%	$0.00 \%$	99.79 %	0.22%	0.00%
total sc in %	25.54 %	$0.00 \%$	25.54 %	0.06%	0.00%
Total	23,182,969		$0$ 23,182,969	50,000	0	23,232,969
Agenda item 8.3 Election of members of the Nomination Committee - Hans Herman Horn (member)
Ordinær	16,588,542	0	16,588,542	0	6,644,427	23,232,969
votes cast in %	100,00 %	0.00%		0.00 %
representation of sc in %	71,40 %	0.00%	71.40 %	0.00%	28.60 %
total sc in %	18.28 %	0.00%	18.28 %	0.00%	7.32 %
Total	16,588,542		0 16,588,542	o	6,644,427	23,232,969
Agenda item 9 Remuneration to the members of the Nomination Committee
Ordinær	23,176,544	1,320	23,177,864	55,105	0	23,232,969
votes cast in %	99.99 %	0.01%		0.00%
representation of sc in %	99.76 %	0.01%	99.76 %	0.24%	0.00%
total sc in %	25.54 %	0.00%	25,54 %	0.06%	0.00 %
Total	23,176,544		1,320 23,177,864	55,105	0	23,232,969
Agenda item 10 The board of directors' guidelines on determination of salary and other remuneration to leading personnel
Ordinær	22,657,582	500,382	23,157,964	75,005	0	23,232,969
votes cast in %	97,84 %	2,16 %		0.00%
representation of sc in %	97.52 %	2.15 %	99.68%	0.32 %	0.00%
total sc in %	24.96 %	0.55%	25.51 %	0.08%	0.00%
Total	22,657,582 500,382 23,157,964			75,005	0	23,232,969
Agenda item 12.1 Authorisation to increase the share capital in connection with the Company's share option
program for employees and board members
Ordinær	22,601,126	606,838	23,207,964	25,005	0	23,232,969
votes cast in %	97.39 %	2.62 %		0.00 %
representation of sc in %	97.28%	2.61 %	99.89 %	0.11 %	$0.00 \%$
total sc in %	24.90 %	0.67%	25.57 %	0.03%	0.00%
Total	22,601,126 606,838 23,207,964			25,005	o	23,232,969
Agenda item 12.2 Authorisation to increase the share capital
Ordinær	23,151,234	6,730	23,157,964	75,005	0	23,232,969
votes cast in %	99.97%	0.03%		0.00%
representation of sc in %	99.65 %	0.03%	99.68%	0.32%	0.00%
	25.51%	0.01%	25.51%	0.08%	$0.00 \%$
total sc in %

Registrar for the company:

Signature company:

DNB Bank ASA JedenEng $\sim$

NEXT BIOMETRICS GROUP ASA

Share information

Name	Total number of shares Nominal value Share capital Voting rights
Ordinær	90.764.386	1,00 90,764,386.00 Yes
Sum:

§ 5-17 Generally majority requirement
requires majority of the given votes

§ 5-18 Amendment to resolution
Requires two-thirds majority of the given votes
like the issued share capital represented/attended on the general meeting